IDM Pharma Report issue

For profit Phase 1 Phase 2
Founded: Irvine CA United States (1990)
Status: Acquired by Takeda (2009)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: IDM Pharma (0) Acquired (2)

ep-2101 (3 trials)

incomplete freund's adjuvant (1 trial)

Drugs in Phase 1 Trials (3)

Key: IDM Pharma (0) Acquired (3)

ep1090 (1 trial)

ep-1233 (1 trial)

mva-mbn32 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 5
  • # of Trial APIs: 5